GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,638.50p
   
  • Change Today:
      2.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 2,429,959
  • Market Cap: £67,914m
  • RiskGrade: 129

ShareCast News

GSK raises £978m through Haleon share sale 17-Jan-2024 ShareCast
UBS downgrades AstraZeneca to 'sell' 16-Jan-2024 ShareCast
Zantac fallout unfairly weighing on GSK, says Sh... 15-Jan-2024 ShareCast
GSK's Nucala gets fresh approval in China 10-Jan-2024 ShareCast
London close: Stocks finish red after choppy ses... 09-Jan-2024 ShareCast
GSK buys respiratory drug maker Aiolos in $1.4bn... 09-Jan-2024 ShareCast
London close: Stocks fall amid rising geopolitic... 03-Jan-2024 ShareCast
Jefferies upgrades GSK to 'buy', cuts AstraZenec... 03-Jan-2024 ShareCast
GSK buys rights to Hansoh Pharma antibody-drug c... 20-Dec-2023 ShareCast
GSK sees success in Jemperli endometrial cancer ... 18-Dec-2023 ShareCast
GSK seeks to extend RSV vaccine approval in Japan 12-Dec-2023 ShareCast
GSK endometrial cancer treatment gets Europe aut... 11-Dec-2023 ShareCast
GSK receives 'positive' headline results from ph... 27-Nov-2023 ShareCast
London close: Stocks rise ahead of US Fed policy... 01-Nov-2023 ShareCast
GSK hikes guidance after strong third quarter 01-Nov-2023 ShareCast
GSK's Jemperli sees success in endometrial cance... 30-Oct-2023 ShareCast
GSK HIV injection regimen gets approval in China 26-Oct-2023 ShareCast
GSK hails success in US RSV vaccine trial 25-Oct-2023 ShareCast
GSK nears green light for Jemperli usage in Europe 16-Oct-2023 ShareCast
GSK settles California Zantac lawsuit 11-Oct-2023 ShareCast
GSK inks deal to promote shingles vaccine in China 09-Oct-2023 ShareCast
Sunday newspaper round-up: Renewi, Metro Bank, N... 08-Oct-2023 ShareCast
GSK raises £885.6m from Haleon share sale 06-Oct-2023 ShareCast
GSK's RSV vaccine gets approval in Japan 25-Sep-2023 ShareCast
US FDA approves GSK treatment for myelofibrosis 18-Sep-2023 ShareCast
Japan considering GSK's Nucala drug for sinusiti... 01-Sep-2023 ShareCast
GSK reports positive results from shingles vacci... 23-Aug-2023 ShareCast
Sunday newspaper round-up: White Hydrogen, Bank ... 13-Aug-2023 ShareCast
GSK lifts full-year guidance after 'excellent' Q2 26-Jul-2023 ShareCast
GSK's ViiV gets Europe nod for HIV prophylaxis 24-Jul-2023 ShareCast
GSK gonorrhoea vaccine gets FDA fast track desig... 27-Jun-2023 ShareCast
GSK gets an approval in Japan, a recommendation ... 26-Jun-2023 ShareCast
Europe open: Stocks on the defensive after weak ... 23-Jun-2023 ShareCast
GSK reaches settlement in Goetz Zantac lawsuit 23-Jun-2023 ShareCast
US CDC votes to recommend GSK's Arexvy against RSV 22-Jun-2023 ShareCast
GSK unveils positive trial results for vaccine a... 21-Jun-2023 ShareCast
FDA extends review period of GSK blood cancer dr... 16-Jun-2023 ShareCast
GSK gets European approval for RSV vaccine 07-Jun-2023 ShareCast
US FDA accepts GSK supplemental application for ... 06-Jun-2023 ShareCast
GSK sells 2.5% Haleon stake at discount for £804m 12-May-2023 ShareCast
Canadian court dismisses GSK Zantac litigation 12-May-2023 ShareCast
EMA adopts 'positive opinion' of GSK's RSV vacci... 27-Apr-2023 ShareCast
GSK Q1 beats estimates 26-Apr-2023 ShareCast
GSK says EMA validates cancer drug submission 25-Apr-2023 ShareCast
GSK 'sticks two fingers up' as workers vote for ... 19-Apr-2023 ShareCast
GSK to buy Canada's Bellus Health for $2bn 18-Apr-2023 ShareCast
GSK announces positive results from trials of ne... 17-Apr-2023 ShareCast
GSK receives 'positive' results from endometrial... 28-Mar-2023 ShareCast
GSK disagrees with ranitidine evidence ruling in... 24-Mar-2023 ShareCast
Deutsche Bank upgrades GSK to 'buy' 17-Mar-2023 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,638.50p
Change Today 2.50p
% Change 0.15 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 2,429,959
Shares Issued 4,144.88m
Market Cap £67,914m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.47% below the market average80.47% below the market average80.47% below the market average80.47% below the market average80.47% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Price Trend
29.70% above the market average29.70% above the market average29.70% above the market average29.70% above the market average29.70% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
44.11% above the market average44.11% above the market average44.11% above the market average44.11% above the market average44.11% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
24.54% below the market average24.54% below the market average24.54% below the market average24.54% below the market average24.54% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 25-Apr-2024

Time Volume / Share Price
15:30 16 @ 1,638.50p
15:30 44 @ 1,638.50p
15:30 100 @ 1,638.50p
15:30 624 @ 1,638.50p
15:30 166 @ 1,638.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page